Neurometabolites in schizophrenia and bipolar disorder - a systematic review and meta-analysis
about
A review of MR spectroscopy studies of pediatric bipolar disorderMR imaging-detectable metabolic alterations in attention deficit/hyperactivity disorder: from preclinical to clinical studiesDietary supplementation with n-3 fatty acids from weaning limits brain biochemistry and behavioural changes elicited by prenatal exposure to maternal inflammation in the mouse model.Use of proton magnetic resonance spectroscopy in the treatment of psychiatric disorders: a critical update.Antimanic Treatment With Tamoxifen Affects Brain Chemistry: A Double-Blind, Placebo-Controlled Proton Magnetic Resonance Spectroscopy Study.Hippocampal and thalamic neuronal metabolism in a putative rat model of schizophrenia.Bimodal effect of lithium plasma levels on hippocampal glutamate concentrations in bipolar II depression: a pilot study.The Utility of Magnetic Resonance Spectroscopy for Understanding Substance Use Disorders: A Systematic Review of the LiteraturePrefrontal NAA and Glx Levels in Different Stages of Psychotic Disorders: a 3T 1H-MRS Study.A review of altered biochemistry in the anterior cingulate cortex of first-episode psychosis.Brain structure, function, and neurochemistry in schizophrenia and bipolar disorder-a systematic review of the magnetic resonance neuroimaging literature.Decreased brain PME/PDE ratio in bipolar disorder: a preliminary (31) P magnetic resonance spectroscopy study.Synaptic proteins in the postmortem anterior cingulate cortex in schizophrenia: relationship to treatment and treatment response.Reduced frontal glutamate + glutamine and N-acetylaspartate levels in patients with chronic schizophrenia but not in those at clinical high risk for psychosis or with first-episode schizophrenia.Targeting mitochondrially mediated plasticity to develop improved therapeutics for bipolar disorderMultiple levels of impaired neural plasticity and cellular resilience in bipolar disorder: developing treatments using an integrated translational approachGABA and glutamate in schizophrenia: a 7 T ¹H-MRS study.Comparison of inter subject variability and reproducibility of whole brain proton spectroscopy.Altered coupling of regional cerebral blood flow and brain temperature in schizophrenia compared with bipolar disorder and healthy subjectsInvestigation of Heschl's gyrus and planum temporale in patients with schizophrenia and bipolar disorder: a proton magnetic resonance spectroscopy studyHow much do we know about schizophrenia and how well do we know it? Evidence from the Schizophrenia Library.Glutamatergic neurometabolites in clozapine-responsive and -resistant schizophreniaHypo-metabolism of the rostral anterior cingulate cortex associated with working memory impairment in 18 cases of schizophreniaDecreased synaptic and mitochondrial density in the postmortem anterior cingulate cortex in schizophrenia.The Paradoxical Relationship between White Matter, Psychopathology and Cognition in Schizophrenia: A Diffusion Tensor and Proton Spectroscopic Imaging Study.Supplementation of Antipsychotic Treatment with the Amino Acid Sarcosine Influences Proton Magnetic Resonance Spectroscopy Parameters in Left Frontal White Matter in Patients with Schizophrenia.Comparison of Metabolite Concentrations in the Left Dorsolateral Prefrontal Cortex, the Left Frontal White Matter, and the Left Hippocampus in Patients in Stable Schizophrenia Treated with Antipsychotics with or without Antidepressants. ¹H-NMR SpectAdding Sarcosine to Antipsychotic Treatment in Patients with Stable Schizophrenia Changes the Concentrations of Neuronal and Glial Metabolites in the Left Dorsolateral Prefrontal Cortex.Regional decoupling of N-acetyl-aspartate and glutamate in schizophreniaAnterior cingulate cortex choline levels in female adolescents with unipolar versus bipolar depression: a potential new tool for diagnosisSpectral fitting using basis set modified by measured B0 field distribution.Contribution of substantia nigra glutamate to prediction error signals in schizophrenia: a combined magnetic resonance spectroscopy/functional imaging study.Elevated Myo-Inositol, Choline, and Glutamate Levels in the Associative Striatum of Antipsychotic-Naive Patients With First-Episode Psychosis: A Proton Magnetic Resonance Spectroscopy Study With Implications for Glial Dysfunction.Aberrant Hippocampal Connectivity in Unmedicated Patients With Schizophrenia and Effects of Antipsychotic Medication: A Longitudinal Resting State Functional MRI Study.Proton magnetic resonance spectroscopy of the substantia nigra in schizophreniaVentral tegmental area/midbrain functional connectivity and response to antipsychotic medication in schizophrenia.N-acetyl aspartate levels in adolescents with bipolar and/or cannabis use disordersGoing up in smoke? A review of nAChRs-based treatment strategies for improving cognition in schizophrenia.Neuroimaging Biomarkers for PsychosisUpdate on bipolar disorder biomarker candidates.
P2860
Q26991430-B09F8F74-C267-4FAD-A4CC-28D57F6BD6F5Q27002911-79CA47ED-346E-4527-BD87-EAA31B67FF93Q30372082-C149713C-3AE4-49FC-B338-1039EBF9A14EQ30686416-209184C1-7967-4838-9079-632B2E6AF21DQ30760720-47B80529-0F3D-4CEC-9D6A-F8D67C018592Q30849611-4E1C72BB-E1DB-4544-B3A6-80FD9B535C22Q30880781-93527156-F2B9-43D8-B8B9-5BB6408B794BQ30987811-67C68391-0E82-48C0-B199-CAE7BB79D4BCQ31048306-9692BC93-E213-4AC1-B82B-A14775A4BD91Q31155440-1A508B17-4A65-4842-85F3-2D9E92D09226Q33718818-93AABFA2-54C5-4CDF-B7F8-5433D3AFAEA8Q33866397-BBC63902-D9CB-46E8-A06A-82D246C7B33BQ33923576-C994E056-7579-4172-A2B8-0DC5A994C4B1Q34048560-C305A131-4173-4152-A30C-1F6775ACD00FQ34268156-C360B575-D0EC-42BA-8668-C7FFE439B97BQ34268501-1A946D9A-AC31-4C50-90ED-8A9423055D3BQ34446463-07027BC1-95C2-4864-AD82-46F325FA4B64Q34724733-239B675D-A1C8-4550-B6FC-0D376F30B760Q34727281-6C74C6C5-5C21-4F29-A710-E6B5B412E758Q35019612-20CF8086-0CFB-4AC8-900B-AE6CE6C16603Q35213673-1CBC1D24-65C0-4C82-9BBA-83242E83C2C8Q35626964-9A459704-B2D6-43EC-A6EF-5D984D75BFE6Q36093761-A70077E3-C9CA-4AC5-BA89-2FBBEC104723Q36113467-540290CB-800C-4436-A0A3-4A4922449120Q36184932-080CEE5D-B5F6-4FA5-B0A1-5F5751B43931Q36246819-A0CCD016-5DBD-491E-922B-DECBEB1536D5Q36247410-EAA1D2EB-C03F-4C51-B483-5380BF11B0F0Q36247426-B715956F-99B3-4FA2-BD41-D6D4023FA293Q36323522-ECDF9863-33D4-4EFE-891B-52D3F1A6C223Q36424652-9458D014-21A6-4C22-8DF6-82F7C4407003Q36469858-130EC555-86B3-45F9-9B59-C03A3509EC27Q36575926-5D794399-BDFC-4740-AD72-F90E157F911FQ36579965-04212215-9423-43D0-A0AC-4C3F53903640Q36994859-284EC14E-0072-4EC0-B471-FF1039A85C81Q37141400-2FBD8A42-DC60-4DD5-BE26-B9AAF8FCD882Q37584279-4E95F735-3560-4C44-8697-E604E19A8281Q37692050-29624A48-A80C-4A57-90E8-80281E310497Q38171876-97A1D8B8-A825-477B-81B2-6B033EF211ABQ38425649-ED1FF0B6-6FB9-4504-8DB9-70A8902F169FQ38803583-6445A809-78A1-40ED-B5C1-BF32603B3AB5
P2860
Neurometabolites in schizophrenia and bipolar disorder - a systematic review and meta-analysis
description
2012 nî lūn-bûn
@nan
2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Neurometabolites in schizophre ...... matic review and meta-analysis
@ast
Neurometabolites in schizophre ...... matic review and meta-analysis
@en
type
label
Neurometabolites in schizophre ...... matic review and meta-analysis
@ast
Neurometabolites in schizophre ...... matic review and meta-analysis
@en
prefLabel
Neurometabolites in schizophre ...... matic review and meta-analysis
@ast
Neurometabolites in schizophre ...... matic review and meta-analysis
@en
P2093
P2860
P31
P50
P1433
P1476
Neurometabolites in schizophre ...... matic review and meta-analysis
@en
P2093
Adrienne Carol Lahti
Deborah Lowman
Jan den Hollander
Rebecca Jones
P2860
P304
P356
10.1016/J.PSCYCHRESNS.2012.02.003
P407
P577
2012-08-01T00:00:00Z